SAN DIEGO – Anne Wojcicki, CEO and co-founder of the direct-to-consumer genetic profiling company 23andme Inc., made no attempt to avoid the delicate topic of FDA scrutiny, opting instead to embrace the "exciting adventure" that she said her firm is undergoing with U.S. regulators.